Outcome Measures in Clinical Trials for Multiple Sclerosis von van Munster, Caspar E. P., Uitdehaag, Bernard M. J.

Volltext

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant von Steenwijk, Martijn D, Geurts, Jeroen J G, Daams, Marita, Tijms, Betty M, Wink, Alle Meije, Balk, Lisanne J, Tewarie, Prejaas K, Uitdehaag, Bernard M J, Barkhof, Frederik, Vrenken, Hugo, Pouwels, Petra J W

Volltext

A standardized protocol for quantification of saccadic eye movements: DEMoNS von Nij Bijvank, J A, Petzold, A, Balk, L J, Tan, H S, Uitdehaag, B M J, Theodorou, M, van Rijn, L J

Volltext

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study von Balk, Lisanne J., Cruz-Herranz, Andrés, Albrecht, Philipp, Arnow, Sam, Gelfand, Jeffrey M., Tewarie, Prejaas, Killestein, Joep, Uitdehaag, Bernard M. J., Petzold, Axel, Green, Ari J.

Volltext

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis von Balk, L J, Steenwijk, M D, Tewarie, P, Daams, M, Killestein, J, Wattjes, M P, Vrenken, H, Barkhof, F, Polman, C H, Uitdehaag, B M J, Petzold, A

Volltext

Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model von Maia, A.R.R., de Man, J., Boon, U., Janssen, A., Song, J.-Y., Omerzu, M., Sterrenburg, J.G., Prinsen, M.B.W., Willemsen-Seegers, N., de Roos, J.A.D.M., van Doornmalen, A.M., Uitdehaag, J.C.M., Kops, G.J.P.L., Jonkers, J., Buijsman, R.C., Zaman, G.J.R., Medema, R.H.

Volltext

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis von Baranzini, Sergio E., Galwey, Nicholas W., Wang, Joanne, Khankhanian, Pouya, Lindberg, Raija, Pelletier, Daniel, Wu, Wen, Uitdehaag, Bernard M.J., Kappos, Ludwig, Polman, Chris H., Matthews, Paul M., Hauser, Stephen L., Gibson, Rachel A., Oksenberg, Jorge R., Barnes, Michael R.

Volltext

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia von Canté-Barrett, K, Spijkers-Hagelstein, J A P, Buijs-Gladdines, J G C A M, Uitdehaag, J C M, Smits, W K, van der Zwet, J, Buijsman, R C, Zaman, G J R, Pieters, R, Meijerink, J P P

Volltext

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method von Popescu, Veronica, Schoonheim, Menno M, Versteeg, Adriaan, Chaturvedi, Nimisha, Jonker, Marianne, Xavier de Menezes, Renee, Gallindo Garre, Francisca, Uitdehaag, Bernard M J, Barkhof, Frederik, Vrenken, Hugo

Volltext

Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis von Lukas, Carsten, Knol, Dirk L, Sombekke, Madeleine H, Bellenberg, Barbara, Hahn, Horst K, Popescu, Veronica, Weier, Katrin, Radue, Ernst W, Gass, Achim, Kappos, Ludwig, Naegelin, Yvonne, Uitdehaag, Bernard M J, Geurts, Jeroen J G, Barkhof, Frederik, Vrenken, Hugo

Volltext

Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis von Rodriguez-Mogeda, Carla, van Lierop, Zoë Y G J, van der Pol, Susanne M A, Coenen, Loet, Hogenboom, Laura, Kamermans, Alwin, Rodriguez, Ernesto, van Horssen, Jack, van Kempen, Zoé L E, Uitdehaag, Bernard M J, Teunissen, Charlotte E, Witte, Maarten E, Killestein, Joep, de Vries, Helga E

Volltext

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment von Leurs, Cyra E, Podlesniy, Petar, Trullas, Ramon, Balk, Lisanne, Steenwijk, Martijn D, Malekzadeh, Arjan, Piehl, Fredrik, Uitdehaag, Bernard MJ, Killestein, Joep, van Horssen, Jack, Teunissen, CE

Volltext

Disruption of structural and functional networks in long-standing multiple sclerosis von Tewarie, Prejaas, Steenwijk, Martijn D., Tijms, Betty M., Daams, Marita, Balk, Lisanne J., Stam, Cornelis J., Uitdehaag, Bernard M.J., Polman, Chris H., Geurts, Jeroen J.G., Barkhof, Frederik, Pouwels, Petra J.W., Vrenken, Hugo, Hillebrand, Arjan

Volltext

Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis von Sonder, Judith M, Burggraaff, Jessica, Knol, Dirk L, Polman, Chris H, Uitdehaag, Bernard MJ

Volltext

A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement von Sikkes, S A M, de Lange-de Klerk, E S M, Pijnenburg, Y A L, Scheltens, P, Uitdehaag, B M J

Volltext

Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I–III von Oort, Quirien, Dirven, Linda, Sikkes, Sietske A. M., Aaronson, Neil, Boele, Florien, Brannan, Christine, Egeter, Jonas, Grant, Robin, Klein, Martin, Lips, Irene, Narita, Yoshitaka, Sato, Hitomi, Sztankay, Monika, Stockhammer, Günther, Talacchi, Andrea, Uitdehaag, Bernard M. J., Reijneveld, Jaap C., Taphoorn, Martin J. B.

Volltext

No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study von Wattjes, Mike P, van Oosten, Bob W, de Graaf, Wolter L, Seewann, Alexandra, Bot, Joseph C J, van den Berg, René, Uitdehaag, Bernard M J, Polman, Chris H, Barkhof, Frederik

Volltext

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15 von Kappos, Ludwig, Kuhle, Jens, Multanen, Juha, Kremenchutzky, Marcelo, Verdun di Cantogno, Elisabetta, Cornelisse, Peter, Lehr, Lorenz, Casset-Semanaz, Florence, Issard, Delphine, Uitdehaag, Bernard M J

Volltext

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial von Lublin, Fred, Prof, Miller, David H, Prof, Freedman, Mark S, Prof, Cree, Bruce A C, Prof, Wolinsky, Jerry S, Prof, Weiner, Howard, Prof, Lubetzki, Catherine, Prof, Hartung, Hans-Peter, Prof, Montalban, Xavier, Prof, Uitdehaag, Bernard M J, Prof, Merschhemke, Martin, MD, Li, Bingbing, PhD, Putzki, Norman, MD, Liu, Fonda C, PharmD, Häring, Dieter A, PhD, Kappos, Ludwig, Prof

Volltext

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 r... von Comi, Giancarlo, Prof, De Stefano, Nicola, Prof, Freedman, Mark S, Prof, Barkhof, Frederik, Prof, Polman, Chris H, Prof, Uitdehaag, Bernard MJ, Prof, Casset-Semanaz, Florence, MSc, Hennessy, Brian, MSc, Moraga, Margaretha Stam, MSc, Rocak, Sanda, PhD, Stubinski, Bettina, MD, Kappos, Ludwig, Prof

Volltext